Characterization of mouse orofacial pain and the effects of lesioning TRPV1-expressing neurons on operant behavior
© Neubert et al; licensee BioMed Central Ltd. 2008
Received: 20 August 2008
Accepted: 01 October 2008
Published: 01 October 2008
Rodent models of orofacial pain typically use methods adapted from manipulations to hind paw; however, limitations of these models include animal restraint and subjective assessments of behavior by the experimenter. In contrast to these methods, assessment of operant responses to painful stimuli has been shown to overcome these limitations and expand the breadth of interpretation of the behavioral responses. In the current study, we used an operant model based on a reward-conflict paradigm to assess nociceptive responses in three strains of mice (SKH1-Hrhr, C57BL/6J, TRPV1 knockout). We previously validated this operant model in rats and hypothesized in this study that wild-type mice would demonstrate a similar thermal stimulus-dependent response and similar operant pain behaviors. Additionally, we evaluated the effects on operant behaviors of mice manipulated genetically (e.g., TRPV1 k.o.) or pharmacologically with resiniferatoxin (RTX), a lesioning agent for TRPV1-expressing neurons. During the reward-conflict task, mice accessed a sweetened milk reward solution by voluntarily position their face against a neutral or heated thermode (37–55°C).
As the temperature of the thermal stimulus became noxiously hot, reward licking events in SKH1-Hrhr and C57BL/6J mice declined while licking events in TRPV1 k.o. mice were insensitive to noxious heat within the activation range of TRPV1 (37–52°C). All three strains displayed nocifensive behaviors at 55°C, as indicated by a significant decrease in reward licking events. Induction of neurogenic inflammation by topical application of capsaicin reduced licking events in SKH1-Hrhr mice, and morphine rescued this response. Again, these results parallel what we previously documented using rats in this operant system. Following intracisternal treatment with RTX, C57BL/6J mice demonstrated a block of noxious heat at both 48 and 55°C. RTX-treated TRPV1 k.o. mice and all vehicle-treated mice displayed similar reward licking events as compared to the pre-treatment baseline levels. Both TRPV1 k.o. and RTX-treated C57BL/6J had complete abolishment of eye-wipe responses following corneal application of capsaicin.
Taken together, these results indicate the benefits of using the operant test system to investigate pain sensitivity in mice. This ability provides an essential step in the development of new treatments for patients suffering from orofacial pain disorders.
Orofacial pain encompasses a multitude of disorders, including temporomandibular disorders (TMDs), trigeminal neuralgia, headaches, and myofascial pain, and affects an estimated 20% of the U.S. population . Some distinct orofacial pain disorders, such as trigeminal neuralgia and migraine headache have no analogous counterparts in other parts of the body (e.g., below the neck). While systems underlying the orofacial pain pathway appear to be similar to those elsewhere in the body, using the same receptors, neurocircuitry (e.g., c-fibers, Aδ fibers), and neurotransmitters (e.g., substance P, glutamate), it is unclear, however, whether trigeminal pain processing is mediated differently. Therefore, investigating mechanisms affecting the trigeminal system may provide unique treatment options for those suffering from orofacial pain.
To this end, most pain models in rodents, which have typically targeted the hindpaw, have been adapted to the orofacial region. These models involve: the induction of inflammation [2–4]; production nerve injuries [5–7]; neurogenic inflammatory agents (e.g., capsaicin) [8, 9]; formalin [10, 11]; Complete Freund's adjuvant (CFA) . One major limitation in these studies, though, involves the assessment and interpretation of the behavioral responses. Testing in the facial region provides a unique set of hurdles, as many of the behavioral assays require restraining the animals and are often associated with a great degree of time and training on the part of the experimenter. For example, assessment of mechanical sensitivity typically involves holding an animal while applying a von Frey filament to the surface of the skin, but there are visual anticipatory cues to contend with if the animal's eyes are unshielded. Additionally, what experimenter defines as a "painful response" can be as varied as a head withdrawal to freezing, whereby an animal becomes completely unresponsive, which is indistinguishable from a fear response. The investigator can overcome some of these limitations by using a "hands-free" operant design to assess facial pain behaviors.
Operant systems utilizes a reward-conflict paradigm, whereby an animal can decide between receiving a reward or escaping an aversive stimulus [13, 14]. In this case, the animal controls the amount of nociceptive stimulation and can modify its behavior based on cerebral processing [15, 16]. We recently made great strides in bridging the gap in orofacial thermal testing with the development of a novel operant orofacial testing paradigm. We validated and characterized an operant thermal assessment paradigm in rats with both hot  and more recently cold  stimuli, and evaluated this system using a number of pain models, including capsaicin-induced neurogenic inflammation , carrageenan-induced inflammation , and menthol-induced sensitization . However, thus far our assessment of thermal processing has been limited to rats.
The use of mice to evaluate nociception has gained momentum, as most pain induction methods and behavioral assays traditionally applied to rats can be easily scaled for application in mice. The advent of transgenic technology in the mouse has allowed an unprecedented look into basic mechanisms relating to pain modulation. There are many major classes of pain related molecules that have been targeted using transgenic manipulations, including neurotrophins, peripheral factors, opioids, intracellular signal transducers, and non-opioid systems . However, behavioral assessments of pain in mice still primarily use reflex-based methods. Operant tests for mice such as the conditioned place preference task (CPP) have been used extensively in field of addiction research  and, to some degree, in the field of pain research . Recent work in transient receptor potential channel melastatin 8 (TRPM8) knockout mice has also used preference tasks to evaluate the cold processing in the hindpaw [23, 24]. However, these assessments focus on pain induction in the hindpaw. Therefore, we sought to adapt our operant orofacial assay, previously used with rats, for use with mice. Although the nociceptive pathways are generally similar in rats and mice, some behaviors seen in rats are not reliably noted in mice, such as the flinching behavior following injection of formalin . Other differences may exist between the two species that could affect performance on our behavioral assay, such as level of attentiveness, tendency to engage in exploratory behavior, and the rewarding potential of the milk solution.
The current study had several goals. The first goal of this study was to characterize the operant behavior of mice exhibited in the presence of a range of neutral to hot stimuli and evaluate if their behavior is strongly influence by the nociceptive potential of the stimulus, as is true of rats . Additionally, we wanted to evaluate the responses of wild-type (w.t.) mice following induction of pain with and without analgesic intervention. Once we established this behavioral profile in genetically w.t. mice, our second goal was to characterize operant behavior of TRPV1 k.o. mice to thermal stimuli. Original behavioral characterization of this strain has focused on withdrawal latency and innate nocifensive behaviors, but no studies have assessed the behavioral phenotype of this knock out in an operant context. In addition, it is becoming apparent that the encoding of thermal sensations relies on co-expression and interaction among the thermal TRP channels, as well as others. Combining genetic manipulations with pharmacological manipulations can provide insights to the how changes in these channels influence behavior towards thermal stimuli. Thus, our final goal was to compare the behavior exhibited by TRPV1 k.o. mice to w.t. C57BL/6J counterparts treated with resiniferatoxin (RTX), a potent TRPV1 agonist used for lesioning agent TRPV1-expressing neurons. This work will serve to enhance the understanding of how nociceptive processes in the trigeminal system are integrated and will be critical for the advancement of the field of orofacial pain research for the transition into clinical treatments.
Materials and methods
Hairless SKH1-Hr hr , TRPV1 k.o., and age-matched wild-type controls (C57BL/6J) mice were obtained from Jackson Laboratories (Bar Harbor, ME). TRPV1 k.o. and C57BL/6J mice were lightly anesthetized with isoflurane (1–2.5%, inhalation) and their fur was bilaterally removed from the orofacial region using depilatory cream at least 1 day prior to behavioral testing. All mice were food fasted for 15 hrs prior to each facial testing session and provided with standard food chow at the completion of testing. Mice were tested at the same time of the day and weighed weekly to monitor health. A recovery day was included between the testing sessions to minimize nutritional deficits due to fasting. Water was also made available ad libitum before and after testing sessions. The mice were placed into the behavioral procedure room 30 min prior to testing and allowed to acclimate to the temperature and ambient noise of the room. Animal testing procedures and general handling complied with the ethical guidelines and standards established by the Institutional Animal Care & Use Committee at the University of Florida and all procedures complied with the Guide for Care and Use of Laboratory Animals .
General activity assessment – rearing behavior
A potential confounding factor for completing an operant behavioral test (see below) includes strain differences in general activity or due to a specific treatment. For example, if a drug produces significant sedation, one would expect an animal to perform poorly on the operant task, which could provide a false negative result in terms of analgesic-potency for that drug. While no analgesic drug were evaluated in the current study in terms of altered rearing activity, we modified our rat rearing chamber design  to accommodate the testing of the mice to measure rearing activity as an assessment of general behavior. An acrylic cylinder (11 cm diameter × 17.6 cm height) was constructed with aluminum sheets placed both on the floor and on 6.3-cm above the floor. The metal siding was connected to a DC power supply and, in series, to a multi-channel data acquisition module (DATAQ Instruments, Inc) and the floor served as the ground for the circuit. Unrestrained mice were placed separately into each cylinder and the data acquisition system was activated. During a rearing event, the animal would place its front paw on the metal side of the cylinder and this would complete an electrical circuit that registered in the computer. Each session lasted 10 min and the number of contacts, duration of contacts, and the duration of each contact was determined. Animals were tested 7 sessions at the same time of the day (afternoon) over a period of two and a half weeks.
To change the effective size of the test box, we modified our existing rat operant test chamber, which consisted of a 20.3 cm W × 20.3 cm D × 16.2 cm H acrylic box, by placing an acrylic insert (7 cm W × 7 cm D × 8 cm H) onto an elevated platform (6 cm off the floor) to effectively reduce the size of the internal dimensions to better accommodate mice. The existing opening (4 × 6 cm) was which was lined with grounded metal (aluminum) tubing was also reduced to a 1" × 1" opening using an acrylic face plate. This again served as a stimulus thermode when connected to a heated circulating water pump (Model RTE-7 D+, Thermo Electron) . The stimulus temperature was adjusted from neutral to very hot (37 to 55°C) and the stimulus thermode temperature was verified for each experiment using a contact thermometer (Fluke, Model 54II).
Animals were first trained to drink milk while contacting metal tubing in a training box that was of similar dimensions to the thermal testing box. The training boxes do not have connections to the water bath and hence the metal contact was equal to the room temperature. This lead-in training period was necessary to acquaint the animals with the task of locating the reward bottle. Animals were considered trained when they achieved a total of ≥ 1000 licks in the training box. To evaluate the effects of food fasting, a subset of animals were tested first without fasting for three training sessions and then with overnight fasting for three sessions over a period of 2 weeks.
Induction of neurogenic inflammation in the face
We induced pain and nociceptive sensitization in the orofacial region using the neurogenic inflammatory agent, capsaicin as described previously by our group . Briefly, capsaicin cream (0.035%, Chattem, INC, Chattanooga, TN) was liberally applied to facial region of anesthetized (isoflurane, inhalation, 2%) SKH1-Hrhr mice (N = 8) and left on for 5 min. The capsaicin was then removed using a moist paper towel, followed by a 70% EtOH wipe and animals were tested 30 min post-capsaicin application at 47°C. One set of animals (N = 5) was treated in the same manner with capsaicin, but also was administered morphine (s.c., 0.5 mg/kg, 100 μl) between the scapulae immediately post-capsaicin application (30 min prior to testing). Note that the 0.5 mg/kg dose was chosen to minimize side effects such as sedation, as this may significantly impact completion of the operant task .
To evaluate the effects of morphine on feeding and reward behavior at a non-noxious stimulus temperature, we tested a separate group of SKH1-Hrhr mice (N = 10) at 37°C. Five animals received morphine (s.c., 0.5 mg/kg, 100 μl) and five received vehicle (dH2O, s.c., 100 μl) and then were evaluated 30' post-injection using the operant system. The treatments were crossed-over for a second session 1-week later and the treatment groups combined for final analysis.
Resiniferatoxin (RTX) administration
Resiniferatoxin (RTX) is an ultrapotent TRPV1-specific agonist that we have used as a molecular neurosurgical agent to selectively lesion TRPV1-positive afferent neurons [28, 29]. Central administration of RTX or vehicle (0.25% Tween 80 in phosphate buffered saline (PBS), 0.05% ascorbic acid) was achieved by injection into the cisterna magna in TRPV1 k.o. (N = 5/treatment) and their wild-type CB57BL/6 control mice (N = 5/treatment). The skin overlying the occipital and cervical regions of the head and neck was disinfected with Betadine. A 30-gauge needle tip connected to Hamilton syringe via PE-10 tubing was carefully directed to touch the mid- to lower portion of the occiput. Note that contacting the bony surface provided distinct tactile feedback as the tip was sequentially moved caudally until the needle punctured the atlanto-occipital membrane overlying the cisterna magna. RTX (100 μg, 1 μl) or vehicle (1 μl) was injected slowly over 10 seconds to allow the solutions to mix with the cerebrospinal fluid (CSF). Animals recovered for 1-week prior to behavioral testing.
A capsaicin eye-wipe test was completed  prior to and following the injections to assess TRPV1 functionality. Briefly, a 0.1% capsaicin solution (20 μl) was placed onto the cornea of the eye of gently restrained animals and the number of eye wipes was counted for 1 min. A negative response (no wipes) verified RTX-lesioning of TRPV1 afferent neurons and only animals that were negative were used in the final operant comparisons. Capsaicin eye-wipe was also completed on TRPV1 k.o. mice as a negative control for comparison.
Statistical analyses were completed (SPSS Statistical software, SPSS Inc) including Student's T-tests and ANOVAs to evaluate the effects of temperature or treatment on the reward licking outcome measure, and a general linear model for multivariate analysis was used to assess the effects of time and strain on rearing behavior. When significant differences were found, post-hoc comparisons were made using the Tukey HSD. *P < 0.05 was considered significant in all instances.
General activity and rearing behavior
STRAIN (Mean ± SEM)
103.3 ± 9.6
50.6 ± 5.3
53.1 ± 3.8
77.8 ± 12.8
50.6 ± 5.5
71.6 ± 10.4
*58.7 ± 6.4
34.1 ± 5.1
54.8 ± 14.1
70.1 ± 8.0
44.6 ± 7.8
48.3 ± 6.8
72.5 ± 10.5
31.8 ± 3.2
40.1 ± 9.7
*58.0 ± 8.2
33.0 ± 4.7
52.4 ± 8.3
*51.0 ± 5.8
28.9 ± 5.2
37.5 ± 6.3
(F6,176 = 3.5, P = 0.003)
(F6,69 = 2.9, P = 0.014)
(F6,60 = 1.5, P = 0.201)
57.4 ± 6.1
38.6 ± 5.0
48.5 ± 5.7
59.5 ± 8.5
38.5 ± 3.1
56.0 ± 7.2
45.5 ± 7.0
31.3 ± 4.2
41.7 ± 7.1
52.1 ± 7.3
41.6 ± 5.3
54.6 ± 9.1
52.1 ± 7.3
34.6 ± 3.2
36.3 ± 8.3
46.9 ± 7.5
30.2 ± 2.8
39.4 ± 7.1
51.2 ± 7.5
26.0 ± 4.0
37.2 ± 7.9
(F6,168 = 0.46, P = 0.837)
(F6,69 = 1.9, P = 0.093)
(F6,60 = 1.2, P = 0.324)
2. Effects of thermal stimuli on operant behavior (Figure 3)
The mice completed the reward-conflict task in a fashion similar to rats , whereby they would contact a thermode with their face to access a reward bottle, generating an electrical signal that was acquired for analysis (see Figure 1A, Babove). There was a significant increase in reward licking events when animals were fasted overnight (Figure 3A). During the unfasted sessions, there was a significant effect of testing day (F2,72 = 16.95, P < 0.001). The first session had significantly lower licks than the second and third sessions. This initial increase may be due to animals learning the task; however, the outcomes during the fasted sessions were relatively stable, as there was not a significant effect due to test session on licks for the fasted sessions, indicating that the behavior was relatively stable with fasting and not indicative of further learning-related increases.
There was a significant effect of temperature on licking behavior for all three strains: SKH1-Hr hr (F4,49 = 23.61, P < 0.0001), C57BL/6J (F3,19 = 40.26, P < 0.0001), TRPV1 k.o. (F3,19 = 5.89, P = 0.007). Post-hoc analyses revealed that the SKH1-Hr hr and C57BL/6J mice displayed the normal operant pain behavior of significantly decreasing reward-licking performance as the temperature increases into the noxious hot range (Figure 3B, C). The TRPV1 k.o. mice (Figure 3D); however, exhibited a rather flat response with stimulus temperatures of 37–52°C, with no significant decrease in reward licking across this range. There was a significant decrease in reward licking only at the highest temperature tested, 55°C.
3. Effects of neurogenic inflammation on operant behavior
4. Effects of intracisternal RTX on w.t. mice and TRPV1-k.o. mice
For the operant testing, we found at 48°C, the TRPV1-k.o. mice had significantly higher licking events as compared to the C57BL/6J mice, indicating that the k.o. mice were insensitive to the hot stimulus that is within the activation range of TRPV1. When treated with RTX, the C57BL/6J w.t. mice had significantly higher licks as compared to vehicle treated animals, on par with the TRPV1-k.o. mice (Figure 6C). When tested at 55°C, all of the TRPV1-k.o. mice (vehicle, RTX) had significantly lower licks as compared to baseline (37°C, Figure 6B). In TRPV1 k.o. mice, no differences in licking behavior was observed at any of the temperatures between mice treated with RTX as compared to vehicle treated mice (Figure 6B). The RTX-treated CB57BL/6J mice had significantly higher licks as compared to the vehicle treated animals when tested in the noxious heat range. Taken together these results confirm that RTX is specific for TRPV1 and that the effects of pharmacological lesion are not the same as genetic removal of TRPV1. These results indicate that another high-threshold receptor is likely linked to TRPV1. Reduction of this other receptor can reduce sensitivity to high thermal stimuli in the w.t. mice, thus, producing a significantly higher lick output. Note that naïve animals in both the TRPV1-k.o. and C57BL/6J groups performed similarly to the vehicle-treated animals of each respected group (data not shown).
Uncontrolled pain remains a public health epidemic, with countless people suffering from a multitude of disorders that cost society billions of dollars annually. The American Pain Society recently released a statement indicating that translational approaches to pain relief (i.e., bench to bedside) would have "immediate and profound benefits" . Despite significant advances made to our understanding of molecular pain mechanisms, few novel analgesic therapies have managed to reach clinical practice . This failure to translate from bench to beside is in part due to the use of inefficient behavioral assays in animal models of pain. Many assays typically require that the investigator both apply the pain stimulus and evaluate a reflexive response by the animal. This can be both time consuming and highly subjective. The use of these assays to model and quantify pain in animals is a major bottle-neck in the development of new analgesics, and providing obstacles in the validation and optimization of clinical treatment strategies.
The use of mice as the preferred model for pain testing provides the opportunity to utilize genetically-altered (i.e., knock-out) strains to study specific targets related to pain processing. The drawback of behaviorally testing mice relates to difficulties in producing fast and reliable results using an animal known for being skittish and jumpy. In this study, we have overcome these traits using our operant test paradigm by presenting a system whereby the investigator is removed from the field and the animal tests itself. We build on our prior work completed in rat models of orofacial pain [17, 19, 27].
As part of our battery of behavioral assessment assays, we evaluate the effects of a variety of factors (e.g., drugs) on general activity to determine if these factors could have an impact on the ability of an animal to perform the operant task. For example, we previously demonstrated that doses of morphine (≥ 2.5 mg/kg) produced significant reduction of rearing behavior in rats . Another factor that may affect performance relates to inherent differences between strains of animals, as some strains may be relatively more active or inquisitive. Therefore, prior to testing the different mice strains (SKH1-Hrhr, C57BL/6J, TRPV1 k.o.) on the operant device, we evaluated them using the rearing assay. We found that the general activity for these three strains was not so much a factor, as they all had similar responses. In fact the rearing duration/event outcome was virtually identical for each strain by the end of two week acclimation period. We concluded that the general activity or exploratory behavior differences between these strains of mice would not likely influence their ability to complete the operant task. The rearing data indicates a potential habituation to the environment for all strains over the two-week test schedule, with each strain displaying decreased events and duration. However, in contrast, we found that the operant results improved with each session; indicating that motivation and cognitive factors are encouraging the animal to complete the task.
When we decided to modify the existing rat operant unit to test mice, we searched for a mouse that was equivalent to the hairless Sprague-Dawley (S.D.) rat that we routinely use and found that the hairless SKH1-Hrhr mouse strain. While the SKH1-Hrhr mouse is typically used in dermatological studies, it is not the typical strain used in pain studies. Here we demonstrated that this strain indeed follows a normal thermal stimulus response, as compared to the wild-type C57BL/6J mice. Additionally, they respond in the appropriate fashion following capsaicin-induced pain with decreased operant licking behavior, and then with morphine-rescue, with return of licking events to baseline levels in the presence of capsaicin. As demonstrated in Figure 3, they are quick to learn the task, therefore minimizing training time. We find this hairless strain to be extremely docile and easy to handle, more convenient to use, as we do not need to shave them in order to test them. The video clip provides a real-time demonstration of the ease of using these animals. Note how quickly the animals are independently and successfully completing the task once placed in the box. Given these traits, the SKH1-Hrhr mice are certainly appropriate and ideal for use in future pharmacological studies.
Trigeminal nociceptors project to the nucleus caudalis and synapse with second-order neurons in the superficial layers, which are organized in the same way as the dorsal horn of the spinal cord, with the nucleus caudalis being laminated like the dorsal horn in spinal cord [33–36]. In fact, the nucleus caudalis extends and merges with the spinal dorsal horn in the cervical spinal cord  and has been termed the medullary dorsal horn . Neurons within this superficial region have been shown to respond to cooling, cold, warming, and hot stimuli [39–42] and chemical irritants [42, 43]. As it is considered a correlate to the spinal cord dorsal horn, the trigeminal spinal nucleus and trigeminal sensory system provides a relevant region with respect to the understanding of pain mechanisms in general [44, 45]. Given this, we targeted this region using the ultrapotent TRPV1 agonist, RTX, in order to assess changes in orofacial pain.
We found that w.t. C57BL/6J mice treated with RTX had a significant decrease in the ability to sense hot (48°C) and very hot (55°C) stimulus temperatures. This contrasts the response of the TRPV1 k.o. mice, as they were only significantly affected at the hottest (55°C) temperature. These results appear to be inconsistent with the work completed by Caterina, et al., as they demonstrated a significant difference at high temperature stimuli, such as 55°C on the hot plate assay, when comparing the TRPV1 k.o. versus the w.t. mice . This is interesting because the thermal assay difference between the reflex and operant tasks may explain this discrepancy. For example, for the reflex-based hot-plate assay, the difference between the k.o. and w.t. groups may be a function of the wild-type mice being more sensitive to a rapid temperature increase, so the response may be a function of the temperature difference detection plus the thermal pain producing the response. In addition, when within-group effects were evaluated for temperature, there was a decreased latency for both the TRPV1 k.o. and w.t. mice. While these authors did not report on this comparison, there appears to be a significant decrease in hot plate latency in the TRPV1 k.o. group as the stimulus moves to higher temperatures. This is consistent with what we found using the operant test, with a significant decrease in licking outcome at the 55°C stimulus. Collectively, these results indicate that while RTX is specific for the TRPV1 receptor, other receptors co-expressed (e.g., TRPV2) on the same neurons with TRPV1 may be susceptible to the RTX-lesioning effects within the nucleus caudalis. Another possibility is that a population of A-δ fibers expressing TRPV1 is also lesioned following RTX-treatment in the w.t. mice.
When we evaluated the pain sensitivity of these mice using an unlearned-reflexive measure such as the capsaicin eye-wipe assay, the RTX-treated C57BL/6J mice appeared to respond identically as the TRPV1 k.o. mice. This brings up an interesting observation that this particular type of assay is sufficient for evaluating a gross-impairment in the nociceptive signaling pathway. However, it cannot tease out subtle differences uncovered using the operant assay, such as the different responses of these two groups at 55°C. This additional information may be relevant for the development of novel analgesics.
In conclusion, we have successfully used the operant orofacial assay to evaluate and characterize thermal pain sensitivity in mice, thus providing a revolutionary step in the ability to model and study pain. Pain is ultimately experienced as a culmination of complex information from the periphery (including the location, intensity, quality, and time course). While in vitro studies can provide insight into the individual components, adequate behavioral assessment of animal models is requisite for understanding the integration of these components into the perception of pain. These findings demonstrate that operant methods, which reflect physiological and cerebral processing of pain, can provide insights not possible with reflex-based testing alone. Such insight may enhance our understanding of pain and ultimately lead to the ability to treat uncontrollable. This replicates what occurs with humans, whereby a person may need to choose between tolerating pain in order to receive some reward (e.g., going to a nice dinner with a migraine headache versus not going to a bad restaurant with the same type of headache). As pain spans any number of diseases, ranging from diabetes to cancer, providing a means of quickly identifying new analgesic agents would provide a tremendous societal benefit, and this mouse operant system provides such a way.
This work was supported by grant #5R21DE016704-02, National Institute of Dental and Craniofacial Research, and grant #1R43DA026220-01, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA. We thank Dr. Charles Widmer for providing the custom-written Labview software routines used in the analysis of the rearing and operant facial data.
- Lipton JA, Ship JA, Larach-Robinson D: Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993, 124(10):115–121.View ArticlePubMed
- Zhou Q, Imbe H, Dubner R, Ren K: Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J Comp Neurol 1999, 412(2):276–291. 10.1002/(SICI)1096-9861(19990920)412:2<276::AID-CNE7>3.0.CO;2-9View ArticlePubMed
- Imbe H, Iwata K, Zhou QQ, Zou S, Dubner R, Ren K: Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain. Cells Tissues Organs 2001, 169(3):238–247. 10.1159/000047887View ArticlePubMed
- Neubert JK, Maidment NT, Matsuka Y, Adelson DW, Kruger L, Spigelman I: Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res 2000, 871(2):181–191. 10.1016/S0006-8993(00)02440-9View ArticlePubMed
- Lim EJ, Jeon HJ, Yang GY, Lee MK, Ju JS, Han SR, Ahn DK: Intracisternal administration of mitogen-activated protein kinase inhibitors reduced mechanical allodynia following chronic constriction injury of infraorbital nerve in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(6):1322–1329. 10.1016/j.pnpbp.2007.05.016View ArticlePubMed
- Kernisant M, Gear RW, Jasmin L, Vit JP, Ohara PT: Chronic constriction injury of the infraorbital nerve in the rat using modified syringe needle. J Neurosci Methods 2008, 172(1):43–47. 10.1016/j.jneumeth.2008.04.013PubMed CentralView ArticlePubMed
- Vos BP, Strassman AM, Maciewicz RJ: Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci 1994, 14(5 Pt 1):2708–2723.PubMed
- Alvarez P, Saavedra G, Hernandez A, Paeile C, Pelissier T: Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat. Anesthesiology 2003, 99(4):969–975. 10.1097/00000542-200310000-00033View ArticlePubMed
- Pelissier T, Pajot J, Dallel R: The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain 2002, 96(1–2):81–87. 10.1016/S0304-3959(01)00432-8View ArticlePubMed
- Clavelou P, Dallel R, Orliaguet T, Woda A, Raboisson P: The orofacial formalin test in rats: effects of different formalin concentrations. Pain 1995, 62(3):295–301. 10.1016/0304-3959(94)00273-HView ArticlePubMed
- Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R: The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain 2006, 7(12):908–914. 10.1016/j.jpain.2006.04.010View ArticlePubMed
- Ogawa A, Ren K, Tsuboi Y, Morimoto T, Sato T, Iwata K: A new model of experimental parotitis in rats and its implication for trigeminal nociception. Exp Brain Res 2003, 152(3):307–316. 10.1007/s00221-003-1538-xView ArticlePubMed
- Vierck CJ Jr, Hamilton DM, Thornby JI: Pain reactivity of monkeys after lesions to the dorsal and lateral columns of the spinal cord. Exp Brain Res 1971, 13(2):140–158. 10.1007/BF00234083View ArticlePubMed
- Dubner R, Beitel RE, Brown FJ: A behavioral animal model for the study of pain mechanisms in primates. In Pain: New Perspectives in Therapy and Research. Edited by: Weisenberg M, Tursky B. New York: Plenum Press; 1976:155–170.View Article
- Vierck CJ Jr, Kline RH, Wiley RG: Intrathecal substance p-saporin attenuates operant escape from nociceptive thermal stimuli. Neuroscience 2003, 119(1):223–232. 10.1016/S0306-4522(03)00125-8View ArticlePubMed
- Mauderli AP, Acosta-Rua A, Vierck CJ: An operant assay of thermal pain in conscious, unrestrained rats. J Neurosci Methods 2000, 97(1):19–29. 10.1016/S0165-0270(00)00160-6View ArticlePubMed
- Neubert JK, Widmer CG, Malphurs W, Rossi HL, Vierck CJ Jr, Caudle RM: Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116(3):386–395. 10.1016/j.pain.2005.05.011View ArticlePubMed
- Rossi HL, Vierck CJ Jr, Caudle RM, Neubert JK: Characterization of cold sensitivity and thermal preference using an operant orofacial assay. Mol Pain 2006, 2: 37. 10.1186/1744-8069-2-37PubMed CentralView ArticlePubMed
- Neubert JK, Rossi HL, Malphurs W, Vierck CJ Jr, Caudle RM: Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav Brain Res 2006, 170(2):308–315. 10.1016/j.bbr.2006.03.008View ArticlePubMed
- Mogil JS, Grisel JE: Transgenic studies of pain. Pain 1998, 77(2):107–128. 10.1016/S0304-3959(98)00093-1View ArticlePubMed
- Tzschentke TM: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12(3–4):227–462. 10.1111/j.1369-1600.2007.00070.xView ArticlePubMed
- Kam EL, Vry JD, Schiene K, Tzschentke TM: Differential effects of morphine on the affective and the sensory component of carrageenan-induced nociception in the rat. Pain 2008, 136(3):373–379. 10.1016/j.pain.2007.07.027View ArticlePubMed
- Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A: TRPM8 is required for cold sensation in mice. Neuron 2007, 54(3):371–378. 10.1016/j.neuron.2007.02.024View ArticlePubMed
- Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR, Brandt MR, Liu Y, Flores CM, Qin N: Attenuated cold sensitivity in TRPM8 null mice. Neuron 2007, 54(3):379–386. 10.1016/j.neuron.2007.04.017View ArticlePubMed
- Wilson SG, Mogil JS: Measuring pain in the (knockout) mouse: big challenges in a small mammal. Behav Brain Res 2001, 125(1–2):65–73. 10.1016/S0166-4328(01)00281-9View ArticlePubMed
- Council NR: Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academy Press; 1996.
- Neubert JK, Rossi HL, Pogar J, Jenkins AC, Caudle RM: Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors. Behav Brain Funct 2007, 3(1):49. 10.1186/1744-9081-3-49PubMed CentralView ArticlePubMed
- Neubert JK, Mannes AJ, Karai L, Jenkins AC, Zawatski L, Abu-Asab M, Iadarola MJ: Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain 2008, 4(1):3. 10.1186/1744-8069-4-3PubMed CentralView ArticlePubMed
- Neubert JK, Karai L, Jun JH, Kim HS, Olah Z, Iadarola MJ: Peripherally induced resiniferatoxin analgesia. Pain 2003, 104(1–2):219–228. 10.1016/S0304-3959(03)00009-5View ArticlePubMed
- Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, Wellisch OM, Neubert JK, Olah Z, Iadarola MJ: Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004, 113(9):1344–1352.PubMed CentralView ArticlePubMed
- Ness T, Wesselmann U, Stone L, Mantyh P, Neubert JK: The American Pain Society and Translational Pain Research – A position statement from the American Pain Society. American Pain Society; 2007.
- Dionne RA, Witter J: NIH-FDA Analgesic Drug Development Workshop: translating scientific advances into improved pain relief. Clin J Pain 2003, 19(3):139–147. 10.1097/00002508-200305000-00001View ArticlePubMed
- Wall PD, Taub A: Four aspects of trigeminal nucleus and a paradox. J Neurophysiol 1962, 25: 110–126.PubMed
- Mosso JA, Kruger L: Spinal trigeminal neurons excited by noxious and thermal stimuli. Brain Res 1972, 38(1):206–210. 10.1016/0006-8993(72)90605-1View ArticlePubMed
- Price DD, Dubner R, Hu JW: Trigeminothalamic neurons in nucleus caudalis responsive to tactile, thermal, and nociceptive stimulation of monkey's face. J Neurophysiol 1976, 39(5):936–953.PubMed
- Sessle BJ: The neurobiology of facial and dental pain: present knowledge, future directions. J Dent Res 1987, 66(5):962–981.View ArticlePubMed
- Capra NF, Dessem D: Central connections of trigeminal primary afferent neurons: topographical and functional considerations. Crit Rev Oral Biol Med 1992, 4(1):1–52.PubMed
- Gobel S, Hockfield S, Ruda MA: Anatomical similarities between medullary and spinal dorsal horns. Berlin: Quintessence Publishing Co; 1981.
- Dickenson AH, Hellon RF, Taylor DC: Facial thermal input to the trigeminal spinal nucleus of rabbits and rats. J Comp Neurol 1979, 185(1):203–209. 10.1002/cne.901850112View ArticlePubMed
- Hutchison WD, Tsoukatos J, Dostrovsky JO: Quantitative analysis of orofacial thermoreceptive neurons in the superficial medullary dorsal horn of the rat. J Neurophysiol 1997, 77(6):3252–3266.PubMed
- Meng ID, Hu JW, Benetti AP, Bereiter DA: Encoding of corneal input in two distinct regions of the spinal trigeminal nucleus in the rat: cutaneous receptive field properties, responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls, and projections to the parabrachial area. J Neurophysiol 1997, 77(1):43–56.PubMed
- Zanotto KL, Merrill AW, Carstens MI, Carstens E: Neurons in superficial trigeminal subnucleus caudalis responsive to oral cooling, menthol, and other irritant stimuli. J Neurophysiol 2007, 97(2):966–978. 10.1152/jn.00996.2006View ArticlePubMed
- Carstens E, Kuenzler N, Handwerker HO: Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa. J Neurophysiol 1998, 80(2):465–492.PubMed
- Dubner R, Bennett GJ: Spinal and trigeminal mechanisms of nociception. Annu Rev Neurosci 1983, 6: 381–418. 10.1146/annurev.ne.06.030183.002121View ArticlePubMed
- Oliveras JL, Maixner W, Dubner R, Bushnell MC, Duncan G, Thomas DA, Bates R: Dorsal horn opiate administration attenuates the perceived intensity of noxious heat stimulation in behaving monkey. Brain Res 1986, 371(2):368–371. 10.1016/0006-8993(86)90377-XView ArticlePubMed
- Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288(5464):306–313. 10.1126/science.288.5464.306View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.